New Vaccine Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

New Vaccine Trials in Colombia

New Vaccine Trials in Colombia – Human Trials in LATAM

The COVID-19 pandemic continues to pose significant challenges worldwide, prompting researchers and scientists to work diligently towards developing effective vaccines. In Colombia, a country heavily impacted by the virus, new vaccine trials are underway, offering hope for a brighter future.

In this blog, we will explore the latest vaccine trials taking place in Colombia, highlighting their potential impact on controlling the spread of COVID-19 and mitigating its devastating effects. These trials not only represent a significant stride in Colombia’s healthcare efforts but also contribute to the global fight against the ongoing pandemic.

COVID-19 Situation in Colombia

Colombia, like many nations, has experienced the immense impact of the COVID-19 pandemic. The country has faced a substantial number of infections and fatalities, straining its healthcare system. Recognizing the urgency, Colombian researchers, and pharmaceutical companies have embarked on vaccine trials to combat the virus’s spread and protect public health. These trials have garnered support from both the government and international organizations, fostering collaboration and resource sharing for the successful development of vaccines.

Collaboration and Research Initiatives

Successful vaccine trials rely on collaboration between various stakeholders. In Colombia, institutions such as the Colombian National Institute of Health and academic research centers have partnered with international organizations like the World Health Organization (WHO) and the Pan American Health Organization (PAHO). This collaborative environment allows for the exchange of knowledge, expertise, and resources necessary for the efficient conduct of vaccine trials.

Advancements in Vaccine Trials

Colombia is currently engaged in several promising vaccine trials. Among them are trials for mRNA-based vaccines, similar to those developed by Pfizer-BioNTech and Moderna. These vaccines have demonstrated high efficacy rates in preventing COVID-19 infection, and Colombian researchers are assessing their effectiveness in the local population.

In addition, Colombia is participating in trials for vector-based vaccines, such as those developed by AstraZeneca and Johnson & Johnson. These vaccines use harmless viral vectors to deliver genetic material, triggering an immune response. By diversifying the vaccine portfolio through trials with various platforms, Colombia aims to enhance its vaccine coverage and effectiveness.

New Vaccine Trials in Colombia

New Vaccine Trials in Colombia

New Vaccine Trials in Colombia

Ensuring Safety and Efficacy

The vaccine trials in Colombia prioritize safety and efficacy by adhering to rigorous protocols. They involve comprehensive testing on a diverse population, including individuals from different age groups, demographics, and geographical regions. This approach allows researchers to gather robust data on vaccine performance, potential side effects, and immune response patterns.

Moreover, the trials follow international standards and guidelines set by regulatory authorities such as the Colombian National Food and Drug Surveillance Institute (INVIMA). These measures ensure that vaccine candidates undergo thorough evaluation before they can be authorized for widespread use, providing confidence in their safety and efficacy.

Implications for Colombia and Beyond

The successful completion of vaccine trials in Colombia holds immense implications for the country and the global fight against COVID-19. Once a safe and effective vaccine is approved, it will contribute to Colombia’s vaccination campaign, helping to achieve herd immunity and alleviate the burden on healthcare systems.

Furthermore, Colombia’s participation in vaccine trials showcases its commitment to global health and scientific progress. The data collected from these trials can provide valuable insights into the effectiveness of different vaccine platforms and optimize vaccination strategies worldwide.


Colombia’s ongoing vaccine trials mark a significant step towards overcoming the challenges posed by the COVID-19 pandemic. Through collaboration between researchers, institutions, and international organizations, Colombia is advancing in the development of safe and effective vaccines.

As these trials progress, Colombia strengthens its defense against the virus and contributes to the global fight against the pandemic. Each milestone achieved brings us closer to a future where the devastating effects of COVID-19 are mitigated, offering hope, resilience, and inspiration to Colombia and countries around the world.

New Vaccine Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

New Vaccine Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
New Vaccine Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

New Vaccine Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

New Vaccine Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

New Vaccine Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

New Vaccine Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
New Vaccine Trials in Colombia

The Cohortias Team

New Vaccine Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

New Vaccine Trials in Colombia

Network & Partnerships